Cannabis on the NHS for children 'by 2019': Astonishing claim made by UK’s biggest legal ref

Cannabis oil from a specially bred strain of the plant could be available to epileptic children on the NHS as early as next year.

US drugs regulators are expected to approve the use of Epidiolex on Wednesday and GW Pharma, the British manufacturer of the drug, believes the European Medicines Agency will follow suit in months.

That would pave the way for thousands of children like Alfie Dingley, six, and Billy Caldwell, 12, to be prescribed it on the NHS to help control their seizures.

Justin Gover, chief executive of GW Pharma, told The Mail on Sunday: ‘We hope by this time next year that Epidiolex will be approved on the NHS.’

He estimates it could help between 4,000 and 5,000 people with epilepsy in the UK – about half of them children. >>>

Recent Posts

See All
  • LinkedIn - White Circle
Cannabis Banking, Simplified.

Shield's purpose built compliance platform manages the risk, compliance and operational demands associated with banking in the legalized cannabis industry. With Shield's transactional and operational transparency tools, compliance officers are notified of non-compliant activity quickly. 

© 2019 Shield Compliance, LLC ||| 500 Union St., Ste 310 Seattle WA 98101

Website development and management by FI Partners, LLC